The lower rating came from HSBC, which cited too much optimism around its new weight-loss pill, and the strength of Novo ...

That is why the current wave of fake Ozempic-style drugs now circulating in the U.S by unlicensed and often foreign companies ...

Analysis found 25% tariff on pharmaceutical imports would hike U.S. drug costs by nearly $51 billion annually, boosting ...

MedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts. If you want to ...

President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...